Prevalence of Cachexia in Patients Undergoing Chemotherapy

Prevalence and Impact of Cachexia in Cancer Patients Undergoing Chemotherapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01939340

Enrollment

285

Registered

2013-09-11

Start date

2010-04-30

Completion date

2013-05-31

Last updated

2013-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cachexia, Cancer

Brief summary

Cachexia and low nutritional intake are a common phenomena in cancer patients undergoing chemotherapy. The purpose of this study is to assess prevalence of cachexia and low nutritional intake and the impact on quality of life, fatigue and mortality in patients undergoing chemotherapy. Furthermore interactions between these parameters, tumor disease and chemotherapy, respectively.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing chemotherapy at least in the second cycle. * Patients who have signed a written Informed Consent.

Exclusion criteria

* Patients with implanted pacemaker or defibrillator.

Design outcomes

Primary

Measure	Time frame	Description
Nutritional intake	1 day	Nutritional intake will be assessed by 24h-recall, which will be analysed with regard to macronutritients

Secondary

Measure	Time frame	Description
Cachexia	1 day	Cachexia will be evaluated using the patient-generated Subjective Global Assessment.
Quality of life and fatigue	1 day	EORTC QLQ C-30 will be used to assess quality of life and additionally cancer-related fatigue will be evaluated using Brief Fatigue Inventory.
Mortality	6 months	Mortality will be assesses via telephone or consultation of the local death register

Countries

Germany

Outcome results